Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patients

Salvador Vergara1 Juan Macías2 José A. Mira2 José A. García-García1 Nicolás Merchante1 José del Valle1 Laila Abdel-Kader1 Fernando Lozano1 Jesús M. Gómez-Mateos1 and Juan A. Pineda1

首页> 外文期刊>Journal of Antimicrobial Chemotherapy >Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patients

【24h】

Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patients

机译：在HIV / HCV合并感染的患者中，HAART期间低水平的肝酶升高与肝纤维化进展无关

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Objectives: To assess the association between non-severe liver enzyme elevations (LEEs) during antiretroviral treatment and liver fibrosis in HIV/HCV-coinfected patients.

机译：目的：评估抗逆转录病毒治疗期间非严重肝酶升高（LEEs）与HIV / HCV合并感染患者的肝纤维化之间的关系。

著录项

来源
《Journal of Antimicrobial Chemotherapy》 |2007年第1期|87-91|共5页
作者
Salvador Vergara1 Juan Macías2 José A. Mira2 José A. García-García1 Nicolás Merchante1 José del Valle1 Laila Abdel-Kader1 Fernando Lozano1 Jesús M. Gómez-Mateos1 and Juan A. Pineda1;
展开▼
作者单位

Unidad de Enfermedades Infecciosas Hospital Universitario de ValmeSeville Spain;

Unidad de Enfermedades Infecciosas Servicio de Medicina Interna Hospital Universitario de ValmeSeville Spain;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patients. [J] . Vergara S, Macias J, Mira JA, The Journal of Antimicrobial Chemotherapy . 2007,第1期

机译：HAART期间低水平的肝酶升高与HIV / HCV合并感染的患者的肝纤维化进展无关。
2. Differences in liver fibrosis and response to pegylated interferon plus ribavirin in HIV/HCV-coinfected patients with normal vs elevated liver enzymes. [J] . Maida I, Martin Carbonero L, Sotgiu G, Journal of viral hepatitis. . 2010,第12期

机译：HIV / HCV合并肝酶正常或升高的患者肝纤维化和对聚乙二醇化干扰素加利巴韦林反应的差异。
3. Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients [J] . Lapadula Giuseppe, Costarelli Silvia, Chatenoud Liliane, JAIDS: Journal of acquired immune deficiency syndromes . 2015,第3期

机译：HIV单感染和HIV / HCV合并感染的患者使用利托那韦增强蛋白酶抑制剂治疗期间肝酶升高的风险
4. The Effect Of Garcinia Mangostana L Rind Ethanol Extract On Transminase Liver Enzymes And Bilirubin On Liver Fibrosis Rat Model [C] . Triyanta Yuli Pramana, Bambang Poerwanto, Suroto, International Conference on Science and Applied Science . 2019

机译：Garcinia Mangostans L中乙醇提取物对透射酶肝酶和胆红素对肝纤维化大鼠模型的影响
5. Effects of Angiotensin Converting Enzyme Inhibitors on Liver Fibrosis in HIV and Hepatitis C Co-Infection. [D] . Reese, Lindsey J. 2011

机译：血管紧张素转换酶抑制剂对HIV和C型肝炎合并感染中肝纤维化的影响。
6. Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA [O] . Emanuele Focà, Massimiliano Fabbiani, Mattia Prosperi, -1

机译：肝纤维化进展和临床结局相互交织：大量可检测HCV-RNA的HIV / HCV感染患者队列中CD4 + T细胞计数和NRTI暴露的作用
7. Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients [O] . Lapadula G, Costarelli S, Chatenoud L, 2015

机译：HIV单感染和HIV / HCV合并感染的患者使用利托那韦增强蛋白酶抑制剂治疗期间肝酶升高的风险

Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patients

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅